Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?

Virginia G. Kaklamani, William J. Gradishar

Producción científica: Review articlerevisión exhaustiva

84 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer?'. En conjunto forman una huella única.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology